Trial Profile
Study to evaluate the long term safety and efficacy of everolimus in lung transplant recipients with chronic renal insufficiency.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 11 Aug 2015 New trial record